Qualitätsbericht 2022 49 | 70 Thema Fachgebiet Ansprechperson Lindenhofgruppe Kooperationspartner / Sponsor Pre- versus sub-pectoral implant-based breast reconstruction after skinsparing mastectomy or nipple-sparing mastectomy (OPBC-02/ PREPEC): A pragmatic, multicenter, randomized, superiority trial Gynäkologie und Geburtshilfe Dr. med. Thomas Fischer Universitätsspital Basel Importance of exercise training therapy timing with regard to cardiotoxicity and patient preference in early breast cancer patients undergoing adjuvant chemo-therapy (CAPRICE) Onkologie, Hämatologie Dr. med. Christa Baumann Insel Gruppe Co-creating and testing the effectiveness of an integrated peer-to-peer self-management program for breast cancer survivors: A stepped wedge cluster randomized study (COSS-Study) Onkologie, Hämatologie Dr. med. Christa Baumann Krebsliga Schweiz, Schweizer Verein für Pflegewissenschaften Selbstwirksamkeitscoaching, Mammakarzinom im Frühstadium – Pilotstudie Selbstwirksamkeitserwartung (SECOM-PSWE) Onkologie, Hämatologie Dr. med. Christa Baumann ZeTuP, iOMEDICO Brolucizumab in patients insufficiently responsive to Ranibizumab and Aflibercept (2020-00412) Ophthalmologie Dr. med. Christof Hänsli Berner Augenklinik Retrospektive Analyse von Netzhautablösungen mit Makulabeteiligung (2020-02920) Ophthalmologie Dr. med. Christof Hänsli Berner Augenklinik Unsupervised Machine Learning in der Aktivitätsbeurteilung von Makulopathien (2021-01560) Ophthalmologie Dr. med. Christof Hänsli Berner Augenklinik; PD Dr. med. Peter Maloca, Universität Basel und IOB Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of High Dose Aflibercept in Patients with Neovascular Age-related Macular Degeneration Combined Protocol & Feasibility: Study 20968 Ph III - Aflibercept High Dose VAY 865321 - in patients with Age-related Macular Degeneration (20968 PULSAR Study/PXL 245919) Ophthalmologie Prof. Dr. med. Justus G. Garweg BAYER AG Validation of Biomarker Assays for Ophthalmological Diseases (2021-02499) Ophthalmologie Prof. Dr. med. Justus G. Garweg BAYER AG Supportive effect of intravitreal corticosteroids in neovascular AMD insufficiently responsive to anti-VEGF drugs (Real-Life Outcomes of adjunct intravitreal Dexamethasone Implant in Patients treated with anti-VEGF for Diabetic Macular Edema and Exudative Age-Related Macular Degeneration; 2022-00510) Ophthalmologie Prof. Dr. med. Justus G. Garweg Centre Ophtalmologique de la Colline, University Eye Hospital Jules Gonin, Swiss Visio Montchoisi, Kantonsspital Aarau AG, Vista Augenklinik Binningen, Pallas Klinik Olten, Stadtspital Zürich Triemli Response to Brolucizumab treatment-naive and pre-treated eyes diagnosed with wet AMD (2022-02305) Ophthalmologie Prof. Dr. med. Justus G. Garweg Dr. René-Pierre Copt, Centre Ophtalmologique du Valais; Dr. med. habil. (H) Gabor Somfai, Stadtspital Zürich Triemli; Prof. Dr. med. Chiara Maria Eandi, Hôpital ophtalmique Jules-Gonin; Dr. PD med. Aude Ambresin, Swiss Visio Montchoisi
RkJQdWJsaXNoZXIy MzQxOTE=